Extract from the Clinical Evaluation Report for Diemthyl ...

It is therefore very encouraging that T1 hypointense lesions were also reduced with active treatment, from an adjusted mean of 5.6 in the placebo group to 1.5 and 2.1 in the 240mg BID and 240mg TID groups, respectively (p ................
................